These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31588260)

  • 1. Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy.
    Zhang C; Yan L; Gu Z; Zhao Y
    Chem Sci; 2019 Aug; 10(29):6932-6943. PubMed ID: 31588260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional high-
    Chen J; Dong H; Bai L; Li L; Chen S; Tian X; Pan Y
    J Mater Chem B; 2022 Mar; 10(9):1328-1342. PubMed ID: 35018941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy.
    Huang J; Huang Q; Liu M; Chen Q; Ai K
    Front Pharmacol; 2022; 13():844037. PubMed ID: 35250594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization.
    Xie J; Gong L; Zhu S; Yong Y; Gu Z; Zhao Y
    Adv Mater; 2019 Jan; 31(3):e1802244. PubMed ID: 30156333
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kim S; Sundaram A; Mathew AP; Hareshkumar VS; Mohapatra A; Thomas RG; Bui TTM; Moon K; Kweon S; Park IK; Jeong YY
    Biomater Sci; 2023 Sep; 11(18):6177-6192. PubMed ID: 37504889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors.
    Liu Y; Jiang Y; Zhang M; Tang Z; He M; Bu W
    Acc Chem Res; 2018 Oct; 51(10):2502-2511. PubMed ID: 30234960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-Responsive Nanoradiosensitizers for Enhanced Cancer Radiotherapy.
    Xiao W; Zhao L; Sun Y; Yang X; Fu Q
    Small Methods; 2024 Jan; 8(1):e2301131. PubMed ID: 37906050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalase-like metal-organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence.
    Chen Y; Zhong H; Wang J; Wan X; Li Y; Pan W; Li N; Tang B
    Chem Sci; 2019 Jun; 10(22):5773-5778. PubMed ID: 31293764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porous platinum nanoparticles as a high-Z and oxygen generating nanozyme for enhanced radiotherapy in vivo.
    Li Y; Yun KH; Lee H; Goh SH; Suh YG; Choi Y
    Biomaterials; 2019 Mar; 197():12-19. PubMed ID: 30623793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold nanoparticles enhance anti-tumor effect of radiotherapy to hypoxic tumor.
    Kim MS; Lee EJ; Kim JW; Chung US; Koh WG; Keum KC; Koom WS
    Radiat Oncol J; 2016 Sep; 34(3):230-238. PubMed ID: 27730800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-responsive scintillating nanotheranostics for reduced hypoxic radioresistance under ROS/NO-mediated tumor microenvironment regulation.
    Dou Y; Liu Y; Zhao F; Guo Y; Li X; Wu M; Chang J; Yu C
    Theranostics; 2018; 8(21):5870-5889. PubMed ID: 30613268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative strategies for photodynamic therapy against hypoxic tumor.
    Li X; Chen L; Huang M; Zeng S; Zheng J; Peng S; Wang Y; Cheng H; Li S
    Asian J Pharm Sci; 2023 Jan; 18(1):100775. PubMed ID: 36896447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in nanomaterials for treatment of hypoxic tumor.
    Zou MZ; Liu WL; Chen HS; Bai XF; Gao F; Ye JJ; Cheng H; Zhang XZ
    Natl Sci Rev; 2021 Feb; 8(2):nwaa160. PubMed ID: 34691571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conquering the Hypoxia Limitation for Photodynamic Therapy.
    Wan Y; Fu LH; Li C; Lin J; Huang P
    Adv Mater; 2021 Dec; 33(48):e2103978. PubMed ID: 34580926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterials for Tumor Hypoxia Relief to Improve the Efficacy of ROS-Generated Cancer Therapy.
    Ruan C; Su K; Zhao D; Lu A; Zhong C
    Front Chem; 2021; 9():649158. PubMed ID: 33954158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy.
    Zhen W; Weichselbaum RR; Lin W
    Adv Mater; 2023 May; 35(21):e2206370. PubMed ID: 36524978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy.
    Wang H; Jia D; Yuan D; Yin X; Yuan F; Wang F; Shi W; Li H; Zhu LM; Fan Q
    J Nanobiotechnology; 2021 May; 19(1):138. PubMed ID: 33985511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of Gold Nanospikes-Based Nanoradiosensitizers: Cellular Internalization, Radiotherapy, and Autophagy.
    Ma N; Liu P; He N; Gu N; Wu FG; Chen Z
    ACS Appl Mater Interfaces; 2017 Sep; 9(37):31526-31542. PubMed ID: 28816044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.